September 30, 2023

Good morning, every body. Damian Garde right here, filling in for Ed Silverman as soon as extra on one other day of aberrant climate and out-of-office autoreplies. Right here’s hoping yours ends with fewer open browser tabs than it started. Under discover a number of gadgets to get you began, and, as at all times, tell us for those who hear something attention-grabbing on the market.

The Meals and Drug Administration accredited a Pfizer vaccine that goals to guard newborns towards RSV by vaccinating pregnant individuals, STAT tells us. The vaccine, marketed as Abrysvo, beforehand gained approval for adults over the age of 60. Pfizer’s product gained’t be accessible to pregnant individuals till wins the advice of a panel of advisers to the CDC, which is predicted to occur earlier than RSV season begins within the winter.

German drugmaker Boehringer Ingelheim is the newest pharmaceutical firm to sue the federal authorities over a legislation that may permit Medicare to barter sure drug costs, Reuters reports. Echoing earlier lawsuits introduced by Merck, Johnson & Johnson, and PhRMA, Boehringer claims the Inflation Discount Act would violate the First, Fifth, and Eighth Amendments by successfully seizing the corporate’s property, forcing it to name the settlement honest, after which levying extreme fines for noncompliance. Jardiance, a diabetes medication co-marketed by Boehringer, is predicted to be among the many first medication to face negotiation as soon as the legislation takes impact in 2026.

Unlock this text by subscribing to STAT+ and revel in your first 30 days free!